A urine metabolomics study showed that tryptophan metabolism represented a critical pathway in ccRCC, while overexpression of tryptophan 2,3-dioxygenase (TDO) in ccRCC was closely related to high levels of Kyn and can predict immunotherapy resistance [17, 18]. Here, TDO2 is linked to nonpapillary renal cell carcinoma.